Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Will your baby get a hep B vaccine? What RFK panel's ruling means. - 2Promising Speculation Bearings for Portfolio Development in 2024
- 3Lucrative Positions in the Advancing Position Market of 2024
- 4Iran denies launching ballistic missiles towards Kurdistan region of Iraq
- 55 High Limit Outer Hard Drives For Information Stockpiling
- The Main 15 Powerful Business Heads of Today
- Becoming amazing at Systems administration: Individual and Expert Tips
- Flu cases are spiking earlier than usual. What you need to know.
- See the moon shine with Saturn in the southern sky after sunset Dec. 26
- Taco Bell debuts its Baja Blast pie, and the reactions may surprise you
- CDC vaccine panel delays vote to stop recommending hepatitis B shot at birth
- The most effective method to Promoter for Cellular breakdown in the lungs Mindfulness in Your People group
- Figure out How to Adjust Work, Life, and an Internet based Degree
- Turkey, Egypt, Qatar discuss second phase of Gaza ceasefire deal
